Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 26,678 | 129,160 | 0 | 0 | 0 |
| Gross Profit | 26,678 | 129,160 | N/A | N/A | N/A |
| Operating Expenses | 239,862 | 175,532 | 90,140 | 87,433 | 16,679 |
| Operating Income | -213,184 | -46,372 | -90,140 | -87,433 | -16,679 |
| Other Income | 15,219 | 10,132 | 1,955 | 781 | -109 |
| Pre-tax Income | -197,965 | -36,240 | -88,185 | -86,652 | -16,788 |
| Income Tax | -351 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -197,614 | -36,240 | -88,185 | -86,652 | -16,788 |
| Net Income | $-197,614 | $-36,240 | $-88,185 | $-86,652 | $-16,788 |
| EPS Basic Total Ops | -2.07 | -0.39 | -5.89 | -13.49 | -5.58 |
| EPS Basic Continuous Ops | -2.07 | -0.39 | -5.89 | -13.49 | -5.58 |
| EPS Diluted Total Ops | -2.07 | -0.39 | -5.89 | -13.49 | -5.58 |
| EPS Diluted Continuous Ops | -2.07 | -0.39 | -5.89 | -13.49 | -5.58 |
| EPS Diluted Before Non-Recurring Items | -2.07 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-210,212 | $-41,662 | $-86,305 | $-85,660 | $-16,558 |